近年来,ST段抬高型心肌梗死的发生率及病死率在逐年上升,并且由ST段抬高型心肌梗死所导致的并发症也给家庭和社会带来了巨大的经济负担,因此如何有效地挽救濒死的心肌将对患者的临床预后有着深远的影响.目前针对再灌注的心肌保护策略治疗也成为了当今的研究热点之一,并且已经有大量的研究证实,再灌注期的心肌保护治疗在防止心肌梗死面积进一步扩大方面发挥着至关重要的作用.现就ST段抬高型心肌梗死患者的再灌注心肌保护策略研究新进展予以综述.“,”In recent years,the incidence and mortality rates of ST-segment elevation myocardial infarction (STEMI) are sharply increasing.The complications after STEMI also bring large burdens to both family and society.How to effectively salvage the dying myocardium will profoundly influence the clinical prognosis of STEMI patients.Therefore,the treatment strategies of STEMI play an important role in the protection of myocardium.Recently,myocardial protection strategies for reperfusion therapy have become a hot topic.Multiple research studies have confirmed that myocardial protection therapy during reperfusion plays a vital role in the prevention of further enlargement of myocardial infarction size.This review summarized the recent advances in myocardial protection strategies for reperfusion in patients with STEMI.